140 related articles for article (PubMed ID: 34223089)
1. Evaluation of a thrice weekly administration of teicoplanin in the outpatient setting: a retrospective observational multicentre study.
Asumang J; Heard KL; Troise O; Fahmy S; Mughal N; Moore LSP; Hughes S
JAC Antimicrob Resist; 2021 Mar; 3(1):dlab012. PubMed ID: 34223089
[TBL] [Abstract][Full Text] [Related]
2. Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programme.
Lamont E; Seaton RA; Macpherson M; Semple L; Bell E; Thomson AH
J Antimicrob Chemother; 2009 Jul; 64(1):181-7. PubMed ID: 19411678
[TBL] [Abstract][Full Text] [Related]
3. Retrospective analysis of relationships among the dose regimen, trough concentration, efficacy, and safety of teicoplanin in Chinese patients with moderate-severe Gram-positive infections.
Zhou L; Gao Y; Cao W; Liu J; Guan H; Zhang H; Shi Y; Lv W; Cheng L
Infect Drug Resist; 2018; 11():29-36. PubMed ID: 29379306
[TBL] [Abstract][Full Text] [Related]
4. Three-times weekly teicoplanin in the outpatient treatment of acute methicillin-resistant staphylococcal osteomyelitis: a pilot study.
Lazzarini L; Tramarin A; Bragagnolo L; Tositti G; Manfrin V; de LF
J Chemother; 2002 Feb; 14(1):71-5. PubMed ID: 11892903
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of teicoplanin use in the OPAT setting.
Dabrowski H; Wickham H; De S; Underwood J; Morris-Jones S; Logan S; Marks M; Pollara G
Int J Antimicrob Agents; 2020 Mar; 55(3):105888. PubMed ID: 31923571
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacokinetics of teicoplanin and vancomycin.
Harding I; Sorgel F
J Chemother; 2000 Nov; 12 Suppl 5():15-20. PubMed ID: 11131959
[TBL] [Abstract][Full Text] [Related]
7. Increased teicoplanin doses are associated with improved serum levels but not drug toxicity.
Matthews PC; Chue AL; Wyllie D; Barnett A; Isinkaye T; Jefferies L; Lovering A; Scarborough M
J Infect; 2014 Jan; 68(1):43-9. PubMed ID: 24012820
[TBL] [Abstract][Full Text] [Related]
8. Retrospective review of serum teicoplanin concentrations in clinical trials and their relationship to clinical outcome.
MacGowan A; White L; Reeves D; Harding I
J Infect Chemother; 1996; 2(4):197-208. PubMed ID: 29681369
[TBL] [Abstract][Full Text] [Related]
9. Three-times weekly teicoplanin as outpatient treatment of chronic osteoarticular infections.
Tascini C; Tagliaferri E; Di Paolo A; Ciofi L; Del Tacca M; Lambelet P; Menichetti F
J Chemother; 2009 Aug; 21(4):421-5. PubMed ID: 19622461
[TBL] [Abstract][Full Text] [Related]
10. Loading regimen required to rapidly achieve therapeutic trough plasma concentration of teicoplanin and evaluation of clinical features.
Seki M; Yabuno K; Miyawaki K; Miwa Y; Tomono K
Clin Pharmacol; 2012; 4():71-5. PubMed ID: 23236257
[TBL] [Abstract][Full Text] [Related]
11. Twice or thrice weekly levothyroxine provides similar rates of adherence and post-Ramadan euthyroidism compared to daily levothyroxine during Ramadan fasting.
Elsherbiny TM
Thyroid Res; 2023 Dec; 16(1):44. PubMed ID: 38053151
[TBL] [Abstract][Full Text] [Related]
12. Studies on drug monitoring in thrice and once daily treatment with aminoglycosides.
Konrad F; Wagner R; Neumeister B; Rommel H; Georgieff M
Intensive Care Med; 1993; 19(4):215-20. PubMed ID: 8366230
[TBL] [Abstract][Full Text] [Related]
13. Outpatient parenteral antimicrobial therapy: Recent developments and future prospects.
Török ME; Chapman AL; Lessing MP; Sanderson F; Seaton RA
Curr Opin Investig Drugs; 2010 Aug; 11(8):929-39. PubMed ID: 20721835
[TBL] [Abstract][Full Text] [Related]
14. Recommendations to achieve rapid therapeutic teicoplanin plasma concentrations in adult hospitalised patients treated for sepsis.
Brink AJ; Richards GA; Cummins RR; Lambson J;
Int J Antimicrob Agents; 2008 Nov; 32(5):455-8. PubMed ID: 18718742
[TBL] [Abstract][Full Text] [Related]
15. Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages.
Pea F; Viale P; Candoni A; Pavan F; Pagani L; Damiani D; Casini M; Furlanut M
Clin Pharmacokinet; 2004; 43(6):405-15. PubMed ID: 15086277
[TBL] [Abstract][Full Text] [Related]
16. Intravenous administration of gentamicin once daily versus thrice daily in adults.
Raz R; Adawi M; Romano S
Eur J Clin Microbiol Infect Dis; 1995 Feb; 14(2):88-91. PubMed ID: 7758492
[TBL] [Abstract][Full Text] [Related]
17. Results of a randomized crossover study comparing once-daily and thrice-daily sevelamer dosing.
Fischer D; Cline K; Plone MA; Dillon M; Burke SK; Blair AT
Am J Kidney Dis; 2006 Sep; 48(3):437-44. PubMed ID: 16931217
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics of teicoplanin.
Wilson AP
Clin Pharmacokinet; 2000 Sep; 39(3):167-83. PubMed ID: 11020133
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of serum teicoplanin concentrations following daily or alternate daily dosing in healthy adults.
Rouveix B; Jehl F; Drugeon H; Brumpt I; Caulin E
Antimicrob Agents Chemother; 2004 Jul; 48(7):2394-9. PubMed ID: 15215086
[TBL] [Abstract][Full Text] [Related]
20. Teicoplanin pharmacokinetics in healthy volunteers after administration of intravenous loading and maintenance doses.
Outman WR; Nightingale CH; Sweeney KR; Quintiliani R
Antimicrob Agents Chemother; 1990 Nov; 34(11):2114-7. PubMed ID: 2149920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
